PHARMACY

FDA approves new use of first U.S.-approved follow-on biologic

BY Alaric DeArment

PRINCETON, N.J. The FDA approved Sandoz Omnitrope (somatropin [rDNA origin]) as a treatment for idiopathic short stature, abnormally short stature not related to growth hormone deficiency, Sandoz announced Friday. The drug was already approved for growth failure in children, children small for gestational age and adults with growth hormone deficiency.

The FDA approved Sandoz’ Omnitrope (somatropin [rDNA origin]) as a treatment for idiopathic short stature, abnormally short stature not related to growth hormone deficiency, Sandoz announced Friday. The drug already was approved for growth failure in children, children small for gestational age and adults with growth hormone deficiency.

“We are pleased to help make Omnitrope easier to access for a wider range of patients with growth-related conditions through the approval of a new indication and a new patient assistance program,” Sandoz president Don DeGolyer said in a statement. “Making Omnitrope easier to access and use are key components of our commitment to patients and will allow more patients to benefit from this high-quality biopharmaceutical.”

Omnitrope, a follow-on biologic that users Pfizer’s Genotropin as a reference product, received FDA approval in May 2006 under special circumstances. The healthcare reform bill creates a regulatory approval pathway for biosimilars in general, though the regulations have yet to be implemented.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

MemorialCare Health System opens new clinics at Albertsons/Sav-On Pharmacy stores

BY Antoinette Alexander

FOUNTAIN VALLEY, Calif. MemorialCare Health System has announced the opening of three new retail health clinics at Albertsons/Sav-On Pharmacy stores in Huntington Beach, Irvine and Mission Viejo, Calif.

“We are pleased to have entered into this new partnership with MemorialCare, a trusted source for quality health care,” stated Sue Klug, president of Albertsons Southern California division. “This demonstrates how businesses like ours can collaborate with healthcare organizations to ensure the communities and families we serve have additional access to health services.”

The new retail clinics, called MemorialCare HealthExpress, are staffed by nurse practitioners and offer treatment for adults and children over the age of 2 years for such common illnesses as colds, flu, sore throats, earaches, sinus infections, skin conditions and minor wounds. Other services include vaccinations and annual flu shots, which currently are available.

“Our MemorialCare Health Express retail clinics make health care easier, affordable and convenient,” stated Barry Arbuckle, president and CEO of MemorialCare Health System. “These clinics expand the options available to patients and also link consumers to primary care physicians by helping them locate a physician if they don’t already have one.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Giant Eagle selects pharmacy workflow automation system

BY Michael Johnsen

SAN DIEGO RxSafe on Thursday announced the installation of its RxSafe 1800 system at a Giant Eagle in the Pittsburgh market.

The RxSafe system is a pharmacy workflow automation system for prescription medication in native packaging. The system allows pharmacies to accurately fill and track prescriptions, manage inventory, eliminate theft and diversion, and avoid expired product. The customizable RxSafe system stores and automates up to 5,400 native prescription containers in less than 40 sq. ft. of space and realizes a peak capacity of up to 500 scripts per hour in multi-operator mode.

“We’re honored to have our leadership in pharmacy automation technology validated by Giant Eagle’s interest in our new system,” stated William Holmes, RxSafe CEO.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?